May 9, 2021


Your News Buddy

More resources on types for your COVID-19 reporting toolbox

About Tara Haelle

Tara Hele (@Tarahale) Is the AHCJ Leading topic in medical studiesIt allows journalists to translate the evidence into accurate information, guided by German science and research.

Back in January, AHCJ’s Chief of Staff for Infectious Diseases Bara Vida a Helpful post On resources to monitor COVID-19 types. But in the age of COVID, information travels fast enough to give us a constant whip, and much has changed since then. The number of the most significant change Types of concern – A word not yet specified at the time of Vida’s post – at least five has grown

  • 1.1.7 (UK)
  • 1.351 (South Africa)
  • 1 (Brazil)
  • 1,427 and B.1.429 (California)

Scientists have also learned much about the individual mutations in each variant, such as how they can benefit the virus and how they can overlap these differences.

Below is a list of resources that can be used to report differences, especially if you are trying to delve deeper into the science of mutation. In addition to a list of Vida sources, I have also added my own recommendations for interviews on differences, as well as a Twitter account I have created to follow their details. Some of the resources below will replicate those in the Vada list, but for her good background information I recommend you read the blog post first.

List of possible sources (in alphabetical order)

  • Kristian Anderson, Professor, Department of Immunology and Microbiology, Scripts Research
  • Trevor Bedford, Associate Professor, Department of Immunization and Infectious Diseases, Fred Hut
  • Kenny Beckman, A senior science consultant and former co-founder of COO and Corbiome (now called Divine)
  • Von S. CooperProfessor of Microbiology and Molecular Genetics at the University of Pittsburgh
  • Joseph Faver, Associate Research Scientist in Epidemiology, Y. University
  • Stephen Goldstein, A graduate researcher at the University of Utah
  • Nathan Grubug, Assistant Professor of Epidemiology (Microbiology), Yale University
  • Bill Hanage, Associate Professor of Epidemiology, Harvard School of Public Health
  • Jeremy Camille, Associate Professor of Microbiology and Immunology, LSL Health Shreveport
  • Ilhem Masawudi, Professor of Molecular Biology and Biochemistry and Director of Irvine Research Center at Irvin University in California
  • Mi Michel C. Nut Branch, Professor and senior physician at Rockefeller University.
  • Angie Rasmussen, Virologist (during transition)
  • Pavitra Roychoudhury, Research Fellow, Department of Vaccination and Infectious Diseases, Fred Huchinson Cancer Research Center
  • Eric Topol, Professor of Molecular Therapy, Director and Founder of Scrip Research and Script Research Translation Translation Institute
  • Susan R., Professor of Microbiology, University of Pennsylvania Perelman School of Medicine